Current Pharmaceutical Design

Author(s): Giuseppe Lassandro, Loredana Ciaccia, Anna Amoruso, Valentina Palladino, Viviana V. Palmieri and Paola Giordano*

DOI: 10.2174/1381612826666201021125512

DownloadDownload PDF Flyer Cite As
Focus on MicroRNAs as Biomarker in Pediatric Diseases

Page: [826 - 832] Pages: 7

  • * (Excluding Mailing and Handling)

Abstract

Background: MiRNAs are a class of small non-coding RNAs that are involved in the post-transcriptional regulation of gene expression. MiRNAs are considered a class of epigenetic biomarkers. These biomarkers can investigate disease at different stages: diagnosis, therapy or clinical follow-up.

Objective: The aim of this paper is to highlight the innovative use of miRNAs in several childhood diseases.

Methods: We conducted a literature review to search the usage of miRNAs in pediatric clinical routine or experimental trials.

Results: We found a possible key role of miRNAs in different pediatric illnesses (metabolic alterations, coagulation defects, cancer).

Conclusion: The modest literature production denotes that further investigation is needed to assess and validate the promising role of miRNAs as non-invasive biomarkers in pediatric disorders.

Keywords: MicroRNAs, pediatrics, children, biomarker, hemophilia, cancer, autism, metabolic syndrome.